跳到正文
今天11月8日周日1 条
  1. STAT · 医学与生命科学新闻

    美国心脏协会科学年会展出三项研究:卒中后及2型糖尿病人群降血压治疗在研究与实践中的挑战

    三项研究周六在美国心脏协会芝加哥科学年会上展出,探讨卒中及2型糖尿病人群的降压策略。其中一项小型但人群多样的试验测试卒中后使用一种常用利尿剂,另一项研究强化治疗以达成低于标准的卒中后血压目标,第三项探索2型糖尿病患者更积极的降压。文中指出高血压升高这些人群严重心血管事件风险、治疗需跨专科协作,新闻稿未给出具体结果数据。

11月7日周六
  1. ClinicalTrials.gov API v2 · 登记更新

    BrainGate2:失语人群皮质内神经接口系统可行性研究(BG-Aphasia-01,NCT07791459)在 ClinicalTrials.gov 登记

    责任方 Leigh R. Hochberg, MD, PhD 在 ClinicalTrials.gov 登记 BrainGate2 皮质内神经接口系统用于失语人群的可行性研究(BG-Aphasia-01,NCT07791459)。研究目的为获得初步器械安全性信息,并以尝试说话的方式验证失语者在计算机屏幕上生成文字及可听见的计算机生成语音的原理可行性。本次为登记摘要,未提供招募状态、分期或结果数据。

11月6日周五
  1. EMA · What's New

    神经内科:Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 28, Status: Authorised

    原文摘录:Aldurazyme RSS Authorised This medicine is authorised for use in the European Union laronidase Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview This is a summary of the European public assessment re … This page was last updated on 06/11/2026

  2. EMA · What's New

    神经内科:Human medicines European public assessment report (EPAR): Lacosamide Accord, lacosamide, Date of authorisation: 18/09/2017, Revision: 14, Status: Authorised

    原文摘录:Lacosamide Accord RSS Authorised This medicine is authorised for use in the European Union lacosamide Medicine Human Authorised Application under evaluation CHMP opinion European Commission decision Overview This is a summary of the European public assess … 56 KB - DOCX) First published: 28/05/2025 View This page was last updated on 06/11/2026

  3. PubMed · Neurology

    神经内科:Overlooked Writings of Sir William Gowers on Neurology in General Practice, Shorthand, and Education.

    原文摘录:Sir William Richard Gowers (1845-1915), long hailed as the "Father of Clinical Neurology," has been the subject of 2 biographies and many essays relating to his contributions to the study of nervous disorders. … Recovered only through primary source research, these writings broaden our understanding of Gowers' intellectual range, showing him not only as a pioneering specialist in the study of nervous disorders but also as a physician engaged with general medicine and educational reform

  4. PubMed · ACS Applied Materials & Interfaces

    脱细胞羊膜-骨髓间充质干细胞复合物改善小鼠角膜碱烧伤修复的机制研究

    研究者构建脱细胞羊膜复合骨髓来源间充质干细胞(BMSC)的组织工程支架,在小鼠角膜碱烧伤模型中评估其疗效。与单纯羊膜移植或结膜下BMSC注射相比,该复合物更有效减轻角膜混浊与新血管形成、恢复上皮完整性,并降低活性氧和丙二醛水平、恢复线粒体氧化磷酸化(Seahorse检测,伤后14天效果更明显)。

11月5日周四
  1. PubMed · Journal of Clinical Investigation

    研究提示细胞衰老是面肩肱型肌营养不良症(FSHD)的关键病理机制,拉米夫定在小鼠模型中改善相关病变

    研究团队在患者肌肉转录组与FSHD小鼠模型中识别细胞衰老及衰老相关分泌表型(SASP)为早期核心机制,相关信号在MRI未见炎症的肌肉中已可检测,成纤维脂肪祖细胞和巨噬细胞为主要衰老细胞群。在FSHD小鼠模型中,逆转录酶抑制剂拉米夫定(lamivudine, 3TC)显著减少衰老、炎症和纤维化并促进肌肉再生,作者提出衰老干预策略值得临床研究。该治疗证据来自动物模型阶段,尚未经临床验证。

  2. PubMed · The Lancet Infectious Diseases

    病例报告:特立妥单抗(teclistamab)治疗骨髓瘤患者发生淋巴细胞脉络丛脑膜炎病毒脑膜脑炎,联合抗病毒治疗改善

    《The Lancet Infectious Diseases》报道英国一例复发多发性骨髓瘤患者在接受双特异性抗体teclistamab治疗后发生淋巴细胞脉络丛脑膜炎病毒(LCMV)脑膜脑炎,经脑脊液宏基因组二代测序确诊,并有家养啮齿类动物接触史。

11月4日周三
  1. PubMed · SLEEP

    发作性睡病1型患者夜间REM睡眠起始标记的重测稳定性不佳

    一项发表于SLEEP的观察性研究纳入227例未治疗的发作性睡病1型(NT1)儿童和成人,每位患者接受两次夜间多导睡眠图检查。结果显示nSOREMP在两次检查均出现者仅占41.8%,重测一致性差(κ=0.26,95% CI 0.14-0.39);nDREM同样稳定性差。研究者认为其与年龄、MSLT结果和下丘脑分泌素水平相关提示REM调节的变异性,并提出两次PSG均未见nSOREMP也不应排除NT1。

  2. PubMed · Neuron

    神经内科:P2RX7 drives inflammatory microglia and pathogenic extracellular vesicle secretion in tauopathy.

    原文摘录:P2X purinoreceptor 7 (P2RX7), an ATP-gated ion channel, contributes to Alzheimer's disease (AD) progression, but its molecular mechanisms remain unclear. … Thus, P2RX7 regulates the FRM branch point, driving inflammatory microglial transition and EV-mediated spread of tau and toxic mitochondrial molecules and highlighting the P2RX7-EV axis as a therapeutic target in AD

11月3日周二
  1. WHO · Disease Outbreak News OData

    神经内科:Shamonda virus in human - France

    原文摘录:See all DONs related to this event Situation at a glance On 20 October 2026, the National IHR Focal Point (NFP) of France notified WHO regarding the first documented human infection with Shamonda virus (SHAV). … item/2026-DON623

    关注理由:这篇神经内科资料可用于了解领域进展,研究设计、结果和局限性值得一起阅读。

11月2日周一
  1. PubMed · Critical Care

    TTM与TTM2试验二次分析:院外心脏骤停后33°C低温与常温的疗效按缺血负荷与神经学状态未见异质性

    该研究对TTM与TTM2两项随机试验共2789例院外心脏骤停成人患者进行二次分析,采用因果森林与BART等效应导向机器学习方法,评估33°C低温与常温(36.0–37.7°C)对六个月全因死亡率和不良功能结局(mRS 4–6)的影响是否因缺血负荷相关因素及入院时神经学表现而异。

10月29日周四
  1. PubMed · Cancer Cell

    临床前研究:血小板PAR4信号以性别特异方式调控胶质母细胞瘤抗肿瘤免疫

    一项发表于Cancer Cell的研究(PMID 42956742)发现,PAR4介导的血小板反应性增高参与胶质母细胞瘤(GBM)抗肿瘤免疫的性别差异。在小鼠模型中,药物或基因抑制PAR4仅在雌性中延长生存,且该作用依赖雌激素,通过肿瘤微环境中CD8+T细胞浸润与功能增强介导,并与雌激素受体β(ERβ)信号相关。结果来自动物模型,PAR4作为治疗靶点尚需临床验证。

10月28日周三
10月27日周二
  1. medRxiv · 独立预印本

    神经内科:Clinical Significance and Distribution of Cerebrospinal Fluid Type IV Oligoclonal Band Pattern in Neurological Disorders: A Retrospective Analysis

    原文摘录:Background and ObjectivesTo characterize the clinical features and cerebrospinal fluid (CSF) findings of patients exhibiting a type IV oligoclonal band (OCB) pattern, defined by the presence of identical IgG bands in both CSF and serum. … These findings support cautious interpretation of the type IV pattern in routine clinical practice

    关注理由:这条神经内科内容值得查看其研究问题与证据来源,具体结论和适用范围以原文为准。

10月26日周一
10月21日周三
  1. PubMed · Nutrients

    神经内科:How to Implement a Ketogenic Diet Therapy in Developing Countries: Colombian Consensus on Ketogenic Diet Therapy Use in the Management of Adults with Drug-Resistant Epilepsy.

    原文摘录:BACKGROUND/OBJECTIVES: Drug-resistant epilepsy affects up to one-third of patients with epilepsy and is associated with higher morbidity, mortality, trauma events, psychosocial challenges, and decline in quality of life.

    关注理由:这条神经内科内容涉及相关临床或研究问题,建议查看原文中的方法与适用范围。

10月9日周五
  1. PubMed · Experimental Neurology

    联合药物靶向NAD+代谢在Wallerian变性的离体模型中保护中枢与外周轴突(Experimental Neurology 研究)

    一项使用坐骨神经和视神经段的Wallerian变性离体模型研究显示,联合NAMPT抑制剂FK866、烟酰胺核糖(NaR)补充及DLK-JNK抑制剂GNE-3511,可在培养7天内显著保存轴突完整性,抑制SARM1 NADase与DLK-JNK激活,效果与正构抑制剂NB-3相近,神经丝稳定方面可能更优。